Date published: 2026-4-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

nm23-H2 Inhibitors

nm23-H2 inhibitors refers to a group of compounds specifically designed to target and inhibit the activity of the nm23-H2 enzyme. Also known as NME2 (Nucleoside Diphosphate Kinase 2), nm23-H2 is a member of the NME family of proteins that play critical roles in various cellular processes, particularly those related to nucleotide metabolism and signaling. These inhibitors are designed with the purpose of binding to the active site of the nm23-H2 enzyme, thereby blocking its catalytic function. Nm23-H2 is a multifunctional enzyme that is involved in several key cellular processes, including nucleotide phosphorylation, DNA replication, and cell motility. It is believed to have a vital role in regulating the intracellular balance of nucleoside triphosphates, which are essential for DNA and RNA synthesis. Inhibition of nm23-H2 has been the subject of extensive research due to its implications in cancer and other diseases where aberrant nucleotide metabolism and cell motility are observed. The development of nm23-H2 inhibitors relies heavily on structural studies of the enzyme's active site to identify suitable binding pockets for targeted drug design. By exploiting the knowledge of nm23-H2's three-dimensional structure, chemists can synthesize small molecules with specific functional groups that complement the enzyme's active site residues. This molecular design approach enhances the likelihood of potent and selective inhibition. As with many enzyme inhibitors, nm23-H2 inhibitors are subjected to rigorous in vitro and in vivo studies to assess their efficacy, specificity, and safety profiles. These studies involve enzymatic assays, cellular assays, and animal models to understand the inhibitors' mechanisms of action and off-target effects. Furthermore, researchers explore the structure-activity relationships to optimize the compounds' potency and properties.The development of nm23-H2 inhibitors represents an exciting avenue of research in the broader field of enzymology and drug discovery. As our understanding of nm23-H2 and its involvement in cellular processes continues to evolve, the applications of these inhibitors in various biological contexts may become increasingly apparent.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

2′,3′-Dideoxyinosine

69655-05-6sc-205098
sc-205098A
1 mg
5 mg
$41.00
$149.00
(0)

DDL selectively inhibits nm23-H2 by mimicking the natural substrates of the enzyme, thereby competing for its active site. This competitive inhibition results in a decreased availability of nucleotides essential for DNA repair and replication, directly impacting cellular proliferation and DNA maintenance mechanisms.

2′,3′-Dideoxycytidine

7481-89-2sc-205579
sc-205579A
100 mg
250 mg
$154.00
$333.00
(1)

Targets nm23-H2 directly, inhibiting its nucleotide kinase activity. By hindering the enzyme′s capacity to maintain nucleotide balance, ddC disrupts DNA synthesis and repair pathways.

Adefovir dipivoxil

142340-99-6sc-207260
sc-207260A
50 mg
100 mg
$102.00
$251.00
(1)

Inhibits nm23-H2 by incorporating into DNA where nm23-H2 is active, thereby interfering with the enzyme's normal function in nucleotide synthesis and subsequent DNA repair processes.

2′-Deoxy-2′,2′-difluorocytidine

95058-81-4sc-275523
sc-275523A
1 g
5 g
$56.00
$128.00
(1)

Inhibits nm23-H2 through its incorporation into DNA, leading to premature chain termination during DNA replication. This action effectively disrupts the nucleotide metabolism pathway, essential for rapid DNA synthesis in proliferating cancer cells

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

Inhibits nm23-H2 by interfering with the synthesis of thymidylate, a precursor necessary for DNA synthesis. This indirect inhibition affects nm23-H2's role in nucleotide metabolism, leading to disrupted RNA and DNA synthesis

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

MTX inhibits nm23-H2 by targeting the folate pathway, indirectly affecting the availability of purines and pyrimidines for nucleotide synthesis. This reduction in nucleotide availability hampers nm23-H2's function in nucleotide metabolism.

6-Mercaptopurine

50-44-2sc-361087
sc-361087A
50 mg
100 mg
$72.00
$104.00
(0)

6-MP inhibits nm23-H2 by incorporating into nucleotide metabolism pathways as a fraudulent substrate, thereby disrupting the balance of nucleotides required for DNA synthesis and repair.

Clofarabine

123318-82-1sc-278864
sc-278864A
10 mg
50 mg
$185.00
$781.00
(0)

Clofarabine inhibits nm23-H2 by directly interfering with the synthesis of deoxynucleotide triphosphates (dNTPs), leading to a depletion of the substrates necessary for DNA and RNA synthesis.

2-Chloro-2′-deoxyadenosine

4291-63-8sc-202399
10 mg
$144.00
1
(0)

Cladribine inhibits nm23-H2 by being incorporated into DNA and disrupting the enzyme's normal function in nucleotide metabolism.

6-Thioguanine

154-42-7sc-205587
sc-205587A
250 mg
500 mg
$42.00
$54.00
3
(1)

6-TG inhibits nm23-H2 by mimicking guanine in nucleotide metabolism, leading to faulty DNA synthesis. This fraudulent incorporation disrupts nm23-H2's role in nucleotide balance and DNA repair, critical for its antineoplastic activity against leukemia.